These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 33817145)
1. Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer. Chang RX; Cui AL; Dong L; Guan SP; Jiang LY; Miao CX Open Life Sci; 2019 Jan; 14():133-140. PubMed ID: 33817145 [TBL] [Abstract][Full Text] [Related]
2. RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway. Chen H; Cheng ZY; Pan Y; Wang Z; Liu Y; Zhang JQ Hum Cell; 2014 Jul; 27(3):103-10. PubMed ID: 24531877 [TBL] [Abstract][Full Text] [Related]
3. RASAL1 attenuates gastric carcinogenesis in nude mice by blocking RAS/ERK signaling. Chen H; Zhao JY; Qian XC; Cheng ZY; Liu Y; Wang Z Asian Pac J Cancer Prev; 2015; 16(3):1077-82. PubMed ID: 25735335 [TBL] [Abstract][Full Text] [Related]
4. miR-130b-5p promotes proliferation, migration and invasion of gastric cancer cells via targeting RASAL1. Chen H; Yang Y; Wang J; Shen D; Zhao J; Yu Q Oncol Lett; 2018 May; 15(5):6361-6367. PubMed ID: 29731849 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Guan Y; He Y; Lv S; Hou X; Li L; Song J J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063 [TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247 [TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance. Chen H; Yang XW; Zhang H; Yang Q; Wang Z; Liu Y; Lu FL; Zhou BY; Qiu-Xi CH; Lu SL Oncol Lett; 2012 Mar; 3(3):535-540. PubMed ID: 22740946 [TBL] [Abstract][Full Text] [Related]
8. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Xue J; Li Y; Yi J; Jiang H Gastroenterol Res Pract; 2019; 2019():6746970. PubMed ID: 31885544 [TBL] [Abstract][Full Text] [Related]
9. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Zheng YZ; Liang L Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721 [TBL] [Abstract][Full Text] [Related]
10. Reduced expression of RAS protein activator like-1 in gastric cancer. Seto M; Ohta M; Ikenoue T; Sugimoto T; Asaoka Y; Tada M; Mohri D; Kudo Y; Ijichi H; Tateishi K; Otsuka M; Hirata Y; Maeda S; Koike K; Omata M Int J Cancer; 2011 Mar; 128(6):1293-302. PubMed ID: 20473946 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer. Yang Q; Yu Y; Sun Z; Pan Y Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467 [TBL] [Abstract][Full Text] [Related]
12. RASAL1 inhibits HepG2 cell growth via HIF-2α mediated gluconeogenesis. Meng F; Zhang W; Wang Y Oncol Lett; 2017 Dec; 14(6):7344-7352. PubMed ID: 29344173 [TBL] [Abstract][Full Text] [Related]
13. B7-H6 Promotes Cell Proliferation, Migration and Invasion of Non-Hodgkin Lymphoma via Ras/MEK/ERK Pathway Based on Quantitative Phosphoproteomics Data. Yang S; Yuan L; Wang Y; Zhu M; Wang J; Ke X Onco Targets Ther; 2020; 13():5795-5805. PubMed ID: 32606790 [TBL] [Abstract][Full Text] [Related]
14. C1QTNF6 as a novel biomarker regulates cellular behaviors in A549 cells and exacerbates the outcome of lung adenocarcinoma patients. Han M; Wang B; Zhu M; Zhang Y In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):614-621. PubMed ID: 31292940 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of ecotropic viral integration site 2A indicates a poor prognosis and promotes osteosarcoma evolution through activating MEK/ERK pathway. Li S; Yang F; Yang YK; Zhou Y J Recept Signal Transduct Res; 2019 Aug; 39(4):368-372. PubMed ID: 31774019 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer. Li J; Huang H; Li Y; Li L; Hou W; You Z Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700 [TBL] [Abstract][Full Text] [Related]
17. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer. Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515 [TBL] [Abstract][Full Text] [Related]
18. RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1α. Huang Z; Wang R; Wei G; Jiang R; Zheng Y; Tian Y; Chen B; Ye C; Xue M; Yu C Oncol Lett; 2017 Sep; 14(3):3839-3845. PubMed ID: 28927155 [TBL] [Abstract][Full Text] [Related]
19. ERBB2 gene expression silencing involved in ovarian cancer cell migration and invasion through mediating MAPK1/MAPK3 signaling pathway. Yu TT; Wang CY; Tong R Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5267-5280. PubMed ID: 32495860 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor receptor-like-1: a new therapeutic target and unfavorable prognostic indicator for rectal adenocarcinoma. Jia RZ; Zhang JZ; Jing CQ; Li CS; Zhuo HQ J Recept Signal Transduct Res; 2020 Jun; 40(3):257-263. PubMed ID: 32098557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]